FISH - NTRK 3 Gene Rearrangement Assay Test sale cost 1400 AED
Coccidioides Antibody Test sale cost 1430 AED Coccidioides Antibody Test Cost 1,590 د.إ Original price was: 1,590 د.إ.1,430 د.إCurrent price is: 1,430 د.إ.
Enterovirus RNA Detection Qualitative Test sale cost 1370 AED Enterovirus RNA Detection Qualitative Test Cost 1,520 د.إ Original price was: 1,520 د.إ.1,370 د.إCurrent price is: 1,370 د.إ.
Sale!

FISH – NTRK 3 Gene Rearrangement Assay Test Cost

Original price was: 1,560 د.إ.Current price is: 1,400 د.إ.

-10%

The FISH (Fluorescence In Situ Hybridization) – NTRK 3 Gene Rearrangement Assay Test is a sophisticated diagnostic procedure designed to identify rearrangements involving the NTRK3 gene. This gene plays a critical role in the development and function of the nervous system, and its rearrangements can lead to various types of cancer, including certain sarcomas, breast cancer, and thyroid cancer. The test utilizes fluorescent probes to visualize the presence or absence of specific genetic alterations directly within the chromosomes of cells extracted from a patient’s tissue sample. This targeted approach allows for a high degree of specificity and sensitivity in detecting NTRK3 gene rearrangements.

Performed at DNA Labs UAE, a leading facility in genetic and molecular diagnostics, the test is available for a cost of 1400 AED. DNA Labs UAE is equipped with state-of-the-art technology and staffed by experienced professionals, ensuring accurate and reliable test results. The FISH – NTRK 3 Gene Rearrangement Assay Test is crucial for patients suspected of having cancers that may involve NTRK3 gene alterations, as it can provide essential information for diagnosis, prognosis, and determining the most effective treatment strategy, including the possibility of targeted therapy.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

FISH – NTRK 3 GENE REARRANGEMENT ASSAY Test

Test Cost: AED 1400.0

Symptoms, Diagnosis, and Referring Details:

  • Test Name: FISH – NTRK 3 GENE REARRANGEMENT ASSAY Test
  • Components: NTRK3 (15q25.3)
  • Price: 1400.0 AED
  • Sample Condition: Submit formalin fixed paraffin embedded tissue block or three 4 micron sections on Poly L Lysine coated slides. Ship at room temperature. Duly filled Genomics Clinical Information Requisition Form (Form 20) is mandatory.
  • Report Delivery: Sample Daily by 6 pm; Report 4 Working days
  • Method: FISH
  • Test Type: Cancer
  • Doctor: Oncologist
  • Test Department: CYTOGENETICS
  • Pre Test Information: Duly filled Genomics Clinical Information Requisition Form (Form 20) is mandatory.

Test Details:

The FISH (Fluorescence In Situ Hybridization) – NTRK 3 Gene Rearrangement Assay Test is a diagnostic test used to detect rearrangements in the NTRK 3 gene. This gene encodes for a protein called neurotrophic tyrosine kinase receptor 3 (NTRK3) which is involved in cell growth and differentiation. Rearrangements in the NTRK 3 gene can result in the fusion of the NTRK3 gene with another gene, leading to the production of a fusion protein. This fusion protein can then promote uncontrolled cell growth and division, potentially leading to the development of certain types of cancer.

The FISH – NTRK 3 Gene Rearrangement Assay Test uses fluorescent probes that specifically bind to the NTRK3 gene and the gene it is fused with. This allows for the visualization of any rearrangements or fusions involving the NTRK3 gene. The test is typically performed on a tissue sample obtained through a biopsy or surgical procedure.

The results of the FISH – NTRK 3 Gene Rearrangement Assay Test can help guide treatment decisions for patients with cancers that harbor NTRK 3 gene rearrangements. In recent years, targeted therapies that specifically inhibit the activity of the NTRK fusion proteins have been developed and approved for use in patients with NTRK fusion-positive cancers. Identifying NTRK 3 gene rearrangements through this test can help determine if a patient is a candidate for these targeted therapies.

Test Name FISH – NTRK 3 GENE REARRANGEMENT ASSAY Test
Components *NTRK3 (15q25.3)
Price 1400.0 AED
Sample Condition Submit formalin fixed paraffin embedded tissue block or three 4 micron sections on Poly L Lysine coated slides. Ship at room temperature. Duly filled Genomics Clinical Information Requisition Form (Form 20) is mandatory.
Report Delivery Sample Daily by 6 pm; Report 4 Working days
Method FISH
Test type Cancer
Doctor Oncologist
Test Department: CYTOGENETICS
Pre Test Information Duly filled Genomics Clinical Information Requisition Form (Form 20) is mandatory.
Test Details

The FISH (Fluorescence In Situ Hybridization) – NTRK 3 Gene Rearrangement Assay Test is a diagnostic test used to detect rearrangements in the NTRK 3 gene. This gene encodes for a protein called neurotrophic tyrosine kinase receptor 3 (NTRK3) which is involved in cell growth and differentiation.

Rearrangements in the NTRK 3 gene can result in the fusion of the NTRK3 gene with another gene, leading to the production of a fusion protein. This fusion protein can then promote uncontrolled cell growth and division, potentially leading to the development of certain types of cancer.

The FISH – NTRK 3 Gene Rearrangement Assay Test uses fluorescent probes that specifically bind to the NTRK3 gene and the gene it is fused with. This allows for the visualization of any rearrangements or fusions involving the NTRK3 gene. The test is typically performed on a tissue sample obtained through a biopsy or surgical procedure.

The results of the FISH – NTRK 3 Gene Rearrangement Assay Test can help guide treatment decisions for patients with cancers that harbor NTRK 3 gene rearrangements. In recent years, targeted therapies that specifically inhibit the activity of the NTRK fusion proteins have been developed and approved for use in patients with NTRK fusion-positive cancers. Identifying NTRK 3 gene rearrangements through this test can help determine if a patient is a candidate for these targeted therapies.

SKU: TEST-5401